Congenital antithrombin III abnormality and cerebral arterial thrombosis.

2. Harrison MJG, Weisblatt E: A sex difference in the effect of aspirin on "spontaneous" platelet aggregation in whole blood. Thromb Haemost 1983^0:773-774 3. ISIS-2 Collaborative Group: Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2:349-360 4. The Canadian Cooperative Study Group: A randomised trial of aspirin and suLfinpyrazone in threatened stroke. N Engl J Med 1978;299:53-59 5. Dyken ML: Antiplatelet aggregating agents in transient ischaemic attacks and the relationship of risk factors, in Breddin K, Loew D, Liberia K, et al (eds): Prophylaxis of Venous, Peripheral, Cardiac, and Cerebral Vascular Diseases With Acetylsalicylic Acid. Stuttgart, F Schattauer, 1980, pp 141-148 6. Spranger M, Aspey BS, Harrison MJG: Sex difference in antithrombotic effect of aspirin. Stroke 1989;20:34-37 7. Harrison MJG, Pollock SS, Steiner M, Weisblatt E: Inhibitors of "spontaneous" platelet aggregation in whole blood. Atherosclerosis 1985;58:199-203 8. Carter AJ, Heptinstall S: Platelet aggregation in whole blood: The role of thromboxane A2 and adenosine diphosphate. Thromb Haemost 1985^4:612-616